Heparan sulfate proteoglycans in experimental models of diabetes: a role for perlecan in diabetes complications.
Proteoglycans are ubiquitous extracellular proteins that serve a variety of functions throughout the organism. Unlike other glycoproteins, proteoglycans are classified based on the structure of the glycosaminoglycan carbohydrate chains, not the core proteins. Perlecan, a member of the heparan sulfate proteoglycan (HSPG) family, has been implicated in many complications of diabetes. Decreased levels of perlecan have been observed in the kidney and in other organs, both in patients with diabetes and in animal models. Perlecan has an important role in the maintenance of the glomerular filtration barrier. Decreased perlecan in the glomerular basement membrane has a central role in the development of diabetic albuminuria. The involvement of this proteoglycan in diabetic complications and the possible mechanisms underlying such a role have been addressed using a variety of models. Due to the importance of nephropathy among diabetic patients most of the studies conducted so far relate to diabetes effects on perlecan in different types of kidney cells. The various diabetic models used have provided information on some of the mechanisms underlying perlecan's role in diabetes as well as on possible factors affecting its regulation. However, many other aspects of perlecan metabolism still await full elucidation. The present review provides a description of the models that have been used to study HSPG and in particular perlecan metabolism in diabetes and some of the factors that have been found to be important in the regulation of perlecan.
Conde-Knape
K
K
Department of Medicine, Division of Preventive Medicine, Columbia University, 630 W 168th St, New York, NY 10032, USA. kcondek@hotmail.com
D000818:Animals; D001161:Arteriosclerosis / Q000378:metabolism; D001485:Basement Membrane / Q000378:metabolism; D003327:Coronary Disease / Q000378:metabolism; D003928:Diabetic Nephropathies / Q000378:metabolism*; D003929:Diabetic Neuropathies / Q000378:metabolism*; D003930:Diabetic Retinopathy / Q000378:metabolism*; D004195:Disease Models, Animal; D019812:Heparan Sulfate Proteoglycans / Q000378:metabolism*; D006801:Humans; D007515:Islets of Langerhans / Q000378:metabolism; D051379:Mice; D051381:Rats
D019812:Heparan Sulfate Proteoglycans; C071927:perlecan